Total planned funding: $27,305,271
Allocations
Countries/Regions
| Mozambique | $5,628,691 |
| South Africa | $3,436,421 |
| Malawi | $2,560,047 |
| Tanzania | $2,033,822 |
| Haiti | $1,387,205 |
| Côte d'Ivoire | $1,307,798 |
| Uganda | $1,165,583 |
| Eswatini | $1,052,467 |
| Nigeria | $1,020,308 |
| Vietnam | $905,436 |
| Kenya | $738,418 |
| Asia Regional Program | $642,565 |
| Zimbabwe | $624,403 |
| Zambia | $611,070 |
| Rwanda | $564,179 |
| Ethiopia | $521,793 |
| Lesotho | $437,856 |
| Democratic Republic of the Congo | $407,092 |
| Papua New Guinea | $373,969 |
| India | $235,023 |
| Guyana | $223,052 |
| Botswana | $199,421 |
| South Sudan | $196,583 |
| Burundi | $182,510 |
| Central Asia Region | $159,734 |
| Namibia | $152,916 |
| Cambodia | $125,350 |
| Angola | $105,833 |
| Caribbean Region | $75,000 |
| Ukraine | $73,901 |
| Burma | $68,500 |
| Cameroon | $66,892 |
| Dominican Republic | $16,292 |
| Indonesia | $5,141 |
Organizational Types
| Own Agency | $27,305,271 |
Program Areas
| Treatment | $27,305,271 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $18,071,827 |
| PDTX: Treatment: Pediatric Treatment | $5,816,635 |
| HTXD: Treatment: ARV Drugs | $3,416,809 |